Trimi vs BreezeMeds: Pricing, Shipping, and Options Compared
Quick verdict: Trimi emphasizes compounded semaglutide from $99/mo with flat per-dose pricing and free overnight shipping, while BreezeMeds lists semaglutide injection starting at $199/mo and shows oral GLP-1 options from $399. Choose based on whether you prioritize lower starting price and a refund promise or a broader set of dosage forms.
See Trimi pricing and plan details
At-a-glance comparison: Trimi vs BreezeMeds
This comparison focuses on the most distinctive differences: starting price, product types and formulations, shipping and delivery, pricing model and guarantees, and compounding and regulatory notes. All statements below reflect the captured source details for Trimi and BreezeMeds.
| Criteria | Trimi | BreezeMeds |
|---|---|---|
| Starting price | Semaglutide from $99/mo (annual plan) | Semaglutide injection from $199/mo; separate figures show starting at $169 and $199 |
| Product types | Compounded semaglutide and tirzepatide | Injectable and oral semaglutide and tirzepatide listed |
| Shipping | Free overnight, temperature-controlled shipping | Discreet home delivery; shipping described as discreet |
| Pricing model | Flat pricing that never rises as dose increases; same price at every dose | Starting prices shown but fees, billing commitments and associations for some figures were not fully visible |
| Guarantees | 6-month money-back promise; 100% automatic refund if not approved by medical team | No clear refund or money-back promise captured |
| Compounding / regulatory note | Compounded medications are not FDA-approved; prepared by state-licensed 503A pharmacies | Compounded and branded product approval status must be confirmed; not interchangeable |
Pricing and membership: which is clearer
Trimi lists semaglutide from $99/mo on an annual plan and emphasizes flat pricing that does not increase with dose changes. Trimi also states tirzepatide at $125/month and repeats that every dose is the same price. BreezeMeds shows a range of starting prices: semaglutide injection from $199/mo, tirzepatide injection from $299, and oral options from $399, and a separate $169 figure that is not clearly tied to a product. The Trimi sources present a clear flat-per-dose claim and specific monthly figures; BreezeMeds presents multiple starting figures and notes that pricing and eligibility are subject to the live offer.
Check BreezeMeds current starting prices
Formulations and treatment options
Trimi focuses on compounded injectable semaglutide and tirzepatide prepared by compounding pharmacies. BreezeMeds lists both injectable and oral semaglutide and tirzepatide options. If availability of oral formulations is a primary consideration, BreezeMeds explicitly displays oral semaglutide and oral tirzepatide starting figures; Trimi emphasizes compounded injectables in the captured evidence.
Shipping, delivery and fulfillment differences
Trimi specifies free overnight, temperature-controlled shipping. BreezeMeds emphasizes discreet home delivery but does not capture a free overnight shipping claim in the provided evidence. Both describe clinician review and medical appropriateness as conditions for treatment delivery, and both recommend confirming state availability and eligibility before enrollment.
Review Trimi shipping and pharmacy details
Transparency, guarantees, and regulatory notes
Trimi states a 6-month money-back promise with terms and a 100% automatic refund if a person is not approved by the medical team, and it names state-licensed 503A compounding pharmacies with certificates of analysis available on request. Trimi also repeats the regulatory note that compounded medications are not FDA-approved. BreezeMeds notes that medication approval status must be confirmed and that branded and compounded products are not interchangeable; BreezeMeds also notes that fees and billing commitments were not fully visible in the captured evidence.
What the sources do not supply
The captured evidence does not supply full details on insurance acceptance, exact renewal terms for BreezeMeds, a detailed fee schedule for BreezeMeds, or specific outcomes. Do not infer any additional guarantees, insurance coverage, or clinical outcomes beyond what each provider states.
Conclusion: Trimi vs BreezeMeds
Primary keyword recap: Trimi vs BreezeMeds. In the captured evidence, Trimi aims for lower starting pricing on an annual plan, flat per-dose pricing, named compounding pharmacies, free overnight shipping and a 6-month money-back promise. BreezeMeds presents higher posted starting prices for injectables, explicit oral options from $399, and discrete shipping, with some pricing figures and fee details not fully tied to specific products in the captured material.
Compare BreezeMeds formulations and availability
Explore Trimi plans and eligibility
Choose Trimi if you want compounded semaglutide or tirzepatide with a stated starting price of $99/mo on the annual plan, flat pricing that does not change with dose, free overnight shipping, and the captured 6-month money-back promise.
Choose BreezeMeds if you want a provider that lists injectable and oral GLP-1 options with starting prices shown for injectables at $199/mo and oral options displayed from $399 and you need to confirm exact fees and availability during intake.